Annual Total Expenses
$110.72 M
-$26.75 M-19.46%
December 31, 2023
Summary
- As of February 8, 2025, TBPH annual total expenses is $110.72 million, with the most recent change of -$26.75 million (-19.46%) on December 31, 2023.
- During the last 3 years, TBPH annual total expenses has fallen by -$258.77 million (-70.03%).
- TBPH annual total expenses is now -70.03% below its all-time high of $369.48 million, reached on December 31, 2020.
Performance
TBPH Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$26.14 M
-$867.00 K-3.21%
September 30, 2024
Summary
- As of February 8, 2025, TBPH quarterly total expenses is $26.14 million, with the most recent change of -$867.00 thousand (-3.21%) on September 30, 2024.
- Over the past year, TBPH quarterly total expenses has increased by +$1.69 million (+6.91%).
- TBPH quarterly total expenses is now -73.88% below its all-time high of $100.07 million, reached on December 31, 2019.
Performance
TBPH Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
TBPH Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.5% | +6.9% |
| 3 y3 years | -70.0% | -59.8% |
| 5 y5 years | -63.0% | -72.5% |
TBPH Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -63.3% | at low | -50.4% | +9.8% |
| 5 y | 5-year | -70.0% | at low | -73.9% | +9.8% |
| alltime | all time | -70.0% | at low | -73.9% | +9.8% |
Theravance Biopharma Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $26.14 M(-3.2%) |
| Jun 2024 | - | $27.01 M(+5.1%) |
| Mar 2024 | - | $25.71 M(+8.0%) |
| Dec 2023 | $110.72 M(-19.5%) | $23.80 M(-2.6%) |
| Sep 2023 | - | $24.45 M(-14.8%) |
| Jun 2023 | - | $28.70 M(-15.0%) |
| Mar 2023 | - | $33.76 M(+5.2%) |
| Dec 2022 | $137.46 M(-54.4%) | $32.08 M(+22.7%) |
| Sep 2022 | - | $26.14 M(-16.1%) |
| Jun 2022 | - | $31.15 M(-24.2%) |
| Mar 2022 | - | $41.09 M(-22.1%) |
| Dec 2021 | $301.31 M(-18.4%) | $52.74 M(-18.9%) |
| Sep 2021 | - | $65.04 M(-15.6%) |
| Jun 2021 | - | $77.02 M(-21.5%) |
| Mar 2021 | - | $98.15 M(+3.2%) |
| Dec 2020 | $369.48 M(+13.6%) | $95.09 M(+0.2%) |
| Sep 2020 | - | $94.87 M(+8.8%) |
| Jun 2020 | - | $87.18 M(-5.6%) |
| Mar 2020 | - | $92.34 M(-7.7%) |
| Dec 2019 | $325.33 M(+8.8%) | $100.07 M(+28.9%) |
| Sep 2019 | - | $77.63 M(+13.1%) |
| Jun 2019 | - | $68.63 M(-13.1%) |
| Mar 2019 | - | $79.00 M(+0.8%) |
| Dec 2018 | $299.12 M | $78.36 M(+4.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $75.29 M(+4.3%) |
| Jun 2018 | - | $72.18 M(-1.5%) |
| Mar 2018 | - | $73.30 M(-12.4%) |
| Dec 2017 | $275.51 M(+20.2%) | $83.69 M(+36.6%) |
| Sep 2017 | - | $61.27 M(-10.7%) |
| Jun 2017 | - | $68.63 M(+10.8%) |
| Mar 2017 | - | $61.92 M(-2.5%) |
| Dec 2016 | $229.12 M(+2.3%) | $63.53 M(+20.8%) |
| Sep 2016 | - | $52.57 M(-0.8%) |
| Jun 2016 | - | $52.97 M(-11.8%) |
| Mar 2016 | - | $60.05 M(+0.6%) |
| Dec 2015 | $224.03 M(-8.3%) | $59.67 M(+10.9%) |
| Sep 2015 | - | $53.79 M(+2.6%) |
| Jun 2015 | - | $52.43 M(-9.8%) |
| Mar 2015 | - | $58.14 M(-13.5%) |
| Dec 2014 | $244.23 M(+56.0%) | $67.19 M(+19.1%) |
| Sep 2014 | - | $56.40 M(-5.5%) |
| Jun 2014 | - | $59.68 M(-2.1%) |
| Mar 2014 | - | $60.96 M(+37.8%) |
| Dec 2013 | $156.51 M(+12.0%) | $44.26 M(+7.7%) |
| Sep 2013 | - | $41.10 M(+5.5%) |
| Jun 2013 | - | $38.96 M(+21.0%) |
| Mar 2013 | - | $32.20 M |
| Dec 2012 | $139.72 M | - |
FAQ
- What is Theravance Biopharma annual total expenses?
- What is the all time high annual total expenses for Theravance Biopharma?
- What is Theravance Biopharma annual total expenses year-on-year change?
- What is Theravance Biopharma quarterly total expenses?
- What is the all time high quarterly total expenses for Theravance Biopharma?
- What is Theravance Biopharma quarterly total expenses year-on-year change?
What is Theravance Biopharma annual total expenses?
The current annual total expenses of TBPH is $110.72 M
What is the all time high annual total expenses for Theravance Biopharma?
Theravance Biopharma all-time high annual total expenses is $369.48 M
What is Theravance Biopharma annual total expenses year-on-year change?
Over the past year, TBPH annual total expenses has changed by -$26.75 M (-19.46%)
What is Theravance Biopharma quarterly total expenses?
The current quarterly total expenses of TBPH is $26.14 M
What is the all time high quarterly total expenses for Theravance Biopharma?
Theravance Biopharma all-time high quarterly total expenses is $100.07 M
What is Theravance Biopharma quarterly total expenses year-on-year change?
Over the past year, TBPH quarterly total expenses has changed by +$1.69 M (+6.91%)